Urgesin Tablets (5 mg) – Solifenacin Succinate

Composition:

• Active Ingredient: Solifenacin Succinate 5 mg per tablet

Indications:

• Used for the treatment of:
  • Overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and increased urinary frequency.

Mechanism of Action:

• Solifenacin is a selective antagonist of the M3 muscarinic acetylcholine receptor, which helps relax the bladder muscle, reducing the frequency of involuntary contractions and improving bladder capacity.

Dosage:

• The typical starting dose is 5 mg once daily. Depending on the patient’s response, the dose may be increased to 10 mg once daily.
• It can be taken with or without food.

Side Effects:

• Common Side Effects: Dry mouth, constipation, blurred vision, dizziness, and urinary retention.
• Serious Side Effects: Risk of angioedema, severe allergic reactions, and potential for urinary tract infections.

Contraindications:

• Not recommended for individuals with:
  • Known hypersensitivity to solifenacin or any of its components.
  • Urinary retention or gastric retention.
  • Severe ulcerative colitis or myasthenia gravis.

Storage:

• Store at room temperature, away from moisture and direct sunlight.

Precautions:

• Caution is advised in patients with conditions such as renal or hepatic impairment, as dose adjustments may be necessary.
• Monitor for signs of urinary retention, especially in patients with a history of urinary issues.

Patient Counseling:

• Advise taking the medication consistently at the same time each day.
• Encourage patients to report any side effects, especially those affecting vision or urination.
• Discuss lifestyle changes that may help manage symptoms of overactive bladder, such as bladder training and fluid management.

For personalized advice and specific recommendations, always consult with a healthcare professional or refer to the product packaging.